Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 3byo.1

X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one 25 bound to Lck

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.00 Å
Oligo State
monomer
Ligands
1 x SO4: SULFATE ION(Non-functional Binders)
1 x AM9: 6-(2,6-dimethylphenyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Martin, M.W. et al., Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. J.Med.Chem. (2008)
Release Date
2008-12-30
Peptides
Proto-oncogene tyrosine-protein kinase LCK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Proto-oncogene tyrosine-protein kinase LCK

Related Entries With Identical Sequence

2of2.1 | 2of4.1 | 3lck.1